ey0018.9-11 | Cancer treatment, growth and growth hormone therapy | ESPEYB18
M Mizumoto , Y Oshiro , H Pan , F Wang , SC Kaste , A Gajjar , W Chemaitilly , TE. thomas.merchant@stjude.org Merchant
ey0018.10-11 | (1) | ESPEYB18
H Thabit , JN Prabhu , W Mubita , C Fullwood , S Azmi , A Urwin , I Doughty , L Leelarathna
ey0019.1-8 | Genetics | ESPEYB19
K Kyostila , JE Niskanen , M Arumilli , J Donner , MK Hytonen , H Lohi
ey0019.5-6 | Advances in clinical practice | ESPEYB19
C Zheng , H Li , S Rong , L Liu , K Zhen , K Li
ey0019.6-14 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19
GA Robinson , J Peng , H Peckham , A Radziszewska , G Butler , I Pineda-Torra , EC Jury , C Ciurtin
ey0019.11-14 | Weight regulation and endocrine circuits (including interventions) | ESPEYB19
A Shoemaker , H Silver , M Buchowski , J Slaughter , J Yanovski , C Elfers , C Roth , MJ Abuzzahab
ey0019.12-1 | New data on the epidemiology of T2DM in children | ESPEYB19
AOY Wu H, Patterson CC, Zhang X, Ghani RBA, Magliano DJ, Boyko EJ, Ogle GD, Luk
ey0019.14-4 | Steroidogenesis and beyond | ESPEYB19
T Yoshida , K Matsumoto , M Miyado , Y Miyashiro , H Sago , R Horikawa , M Fukami
ey0017.1-5 | Hypopituitarism: Disease Modeling and New Discoveries | ESPEYB17
T Kasai , H Suga , Sakakibara , C Ozone , R Matsumoto , M Kano , K Mitsumoto , K Ogawa , Y Kodani , H Nagasaki , N Inoshita , M Sugiyama , T Onoue , T Tsunekawa , Y Ito , H Takagi , D Hagiwara , S Iwama , M Goto , R Banno , R Takahashi , H Arima
ey0017.2-1 | Neonatal Hypoglycaemia | ESPEYB17
JME Mannisto , M Maria , J Raivo , T Kuulasmaa , T Otonkoski , H Huopio , Laakso